2026-10-19T00:02:12Zhttps://ebyu-rdlopen.rawdatalibrary.net/oai/request

oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/140152026-10-18T21:14:21Zopenairedrivercom_ebyu_10000col_ebyu_10001

The effect of anakinra to nephrotoxicity with cisplatin induced in rats: Biochemical, gene expression and histopathological evaluationOzcicek, AdaletOzcicek, FatihCimen, Ferda KeskinMammadov, RenadCankaya, MuratEzmeci, TalatAltuner, DurduAnakinraCisplatin-nephrotoxicityRatsAnimalsAntineoplastic AgentsAntioxidantsAntirheumatic AgentsCisplatinDrug Administration ScheduleGlutathioneInjections, IntraperitonealInterleukin 1 Receptor Antagonist ProteinKidneyKidney DiseasesMalondialdehydeOxidative StressProtective AgentsRats, Wistardistilled waterinterleukin 1betamalonaldehydeantineoplastic agentantioxidantantirheumatic agentinterleukin 1 receptor blocking agentprotective agentanalysis of varianceanimal experimentanimal tissueArticleBackground. Oxidative stress and interleukin-1 beta (IL-1β) have been reported to play a role in the pathogenesis of nephrotoxicity induced by cisplatin. Objectives. The objective of this study was to investigate the effect of anakinra, which is an IL-1β receptor antagonist, on cisplatin-induced nephrotoxicity in rats, through biochemical, gene expression and histopathological analyses. Material and methods. The study was designed with 4 groups. For 1 week, the control group (C) and the cisplatin (Cis) group received distilled water, while the cisplatin + anakinra 50 (Cis + ANA50) group and the cisplatin + anakinra 100 (Cis + ANA100) group were intraperitoneally administered 50 mg/kg and 100 mg/kg of anakinra, respectively. The Cis, Cis + ANA50 and Cis + ANA100 groups were intraperitoneally injected with a 2.5 mg/kg dose of cisplatin for 7 days. After sacrifice, the kidney tissue of each rat was extracted for the assessment of the malondialdehyde (MDA) and total glutathione (tGSH) levels, and for gene expression analyses of IL-1β. The kidney tissues were histopathologically evaluated. Statistical analyses of the data were performed using one-way analysis of variance (ANOVA). Results. The administration of cisplatin (the Cis group) yielded a higher level of MDA (4.75 ±0.25 nmol/mL; p < 0.001) and lower levels of tGSH (1.80 ±0.35 mg/L; p < 0.001) compared to other groups. Cisplatin also increased IL-1β gene expression (6.33 ±0.27 gene expression levels; p < 0.001) compared to other groups. The impact of anakinra on the MDA and tGSH levels, and on IL-1β gene expression induced by cisplatin was observed as a reversal of these findings (p < 0.05). Anakinra better prevented an increase of the levels of MDA and IL-1β at a dose of 100 mg/kg compared to a 50 mg/kg dose. Conclusions. Anakinra prevents oxidative kidney damage induced by cisplatin in a dose-dependent manner. This result suggests that anakinra may be useful in the treatment of cisplatin-induced kidney damage. © 2018 by Wroclaw Medical University.Wroclaw University of Medicine2018Articlehttps://rdlopen.rawdatalibrary.net/r/ebyu/14015https://doi.org/10.17219/acem/757751899-5276enAdvances in Clinical and Experimental Medicineinfo:eu-repo/semantics/openAccessinfo:eu-repo/semantics/articlehttps://ebyu-rdlopen.rawdatalibrary.net/tr/items/ebyu/14015